£4.2M
The Edinburgh biotech uses the capital to scale its 3D bioprinted tumour models across the UK, Europe, and the US.
C
Carcinotech
Carcinotech manufactures 3D printed tumours from cancer cells for oncology testing and research.
Edinburgh, UK—Founded 2018
£5.8MTotal raised
Life sciences business manufacturing 3D printed tumours from cancer stem cells and primary cells for oncology research.
Categories
Founders
IM
Ishani Malhotra
CEO and founder
Investors
- £4.2MScottish EnterpriseFollow-on
TTRICAPITALFollow-onSIS VenturesFollow-on
GIGabriel InvestmentFollow-onAlba EquityFollow-on
- £1.6M
Funding history
£1.6M
TRICAPITAL led the investment round with backing from a syndicate of Scottish investors.